NASDAQ:EDIT
Editas Medicine, Inc Stock News
$6.00
+0.320 (+5.63%)
At Close: May 15, 2024
Bank of New York Mellon Corp Has $7.69 Million Position in Editas Medicine Inc (NASDAQ:EDIT)
09:50am, Monday, 13'th Apr 2020
Bank of New York Mellon Corp grew its holdings in Editas Medicine Inc (NASDAQ:EDIT) by 3.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The ins
UBS Asset Management Americas Inc. Buys 1,327 Shares of Editas Medicine Inc (NASDAQ:EDIT)
10:36am, Sunday, 12'th Apr 2020
UBS Asset Management Americas Inc. grew its stake in Editas Medicine Inc (NASDAQ:EDIT) by 5.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 27,796 shares of the company’s stock
Ladenburg Thalmann Financial Services Inc. Increases Position in Editas Medicine Inc (NASDAQ:EDIT)
09:36am, Sunday, 12'th Apr 2020
Ladenburg Thalmann Financial Services Inc. grew its holdings in Editas Medicine Inc (NASDAQ:EDIT) by 11.9% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1
Head-To-Head Comparison: Rubius Therapeutics (NASDAQ:RUBY) versus Editas Medicine (NASDAQ:EDIT)
05:16am, Sunday, 12'th Apr 2020
Rubius Therapeutics (NASDAQ:RUBY) and Editas Medicine (NASDAQ:EDIT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of the
Editas Medicine Inc (NASDAQ:EDIT) Given Consensus Rating of "Hold" by Analysts
05:58am, Tuesday, 07'th Apr 2020
Editas Medicine Inc (NASDAQ:EDIT) has been assigned a consensus recommendation of “Hold” from the ten analysts that are presently covering the company, MarketBeat Ratings reports. One research ana
Are Options Traders Betting on a Big Move in Editas Medicine (EDIT) Stock?
12:59pm, Monday, 06'th Apr 2020
Investors need to pay close attention to Editas Medicine (EDIT) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Editas Medicine (EDIT) Stock?
12:59pm, Monday, 06'th Apr 2020
Investors need to pay close attention to Editas Medicine (EDIT) stock based on the movements in the options market lately.
Is CRISPR Therapeutics Stock a Buy?
12:07pm, Sunday, 05'th Apr 2020
What should investors think of this well-known gene-editing company?
Captrust Financial Advisors Grows Stock Holdings in Editas Medicine Inc (NASDAQ:EDIT)
09:34am, Thursday, 02'nd Apr 2020
Captrust Financial Advisors increased its stake in shares of Editas Medicine Inc (NASDAQ:EDIT) by 7,925.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Co
Better Buy: Editas Medicine vs Sangamo Therapeutics
01:31pm, Wednesday, 01'st Apr 2020
Which of these two gene-editing companies is the better investment?
Modalis Obtains Access to Foundational CRISPR IP
04:00am, Wednesday, 01'st Apr 2020
Modalis Therapeutics Corporation (Modalis) today announced that the company has entered into a license agreement with Editas Medicine, Inc., under which Modalis has obtained a license to certain intel
Amalgamated Bank Boosts Stake in Editas Medicine Inc (NASDAQ:EDIT)
08:34am, Tuesday, 31'st Mar 2020
Amalgamated Bank boosted its stake in shares of Editas Medicine Inc (NASDAQ:EDIT) by 8.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Excha
Editas (EDIT) Up 0.1% Since Last Earnings Report: Can It Continue?
03:31pm, Friday, 27'th Mar 2020
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Editas (EDIT) Up 0.1% Since Last Earnings Report: Can It Continue?
03:31pm, Friday, 27'th Mar 2020
Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
If You Had Bought Editas Medicine (NASDAQ:EDIT) Stock A Year Ago, You’d Be Sitting On A 12% Loss, Today
12:30pm, Thursday, 26'th Mar 2020
You can invest in an index fund if you want to make sure your returns approximately match the overall market. In...
